Futura Medical (FUM) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.940x

Based on the latest financial reports, Futura Medical (FUM) has a cash flow conversion efficiency ratio of -0.940x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.64 Million ≈ $-320.73 USD) by net assets (GBX2.81 Million ≈ $341.31 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Futura Medical for the company's overall valuation and market capitalisation.

Futura Medical - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Futura Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Futura Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Futura Medical ranked by their cash flow conversion efficiency. Explore Futura Medical cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Fantasy Network Ltd
TA:FNTS
-0.069x
Hana Microelectronics Public Company Limited
F:HAA1
0.055x
Meren Energy Inc.
TO:MER
0.166x
Sabien Technology Group Plc
LSE:SNT
0.043x
Orient Europharma Co Ltd
TWO:4120
-0.020x
iLearningEngines, Inc.
NASDAQ:AILEQ
-3.216x
PTT Global Chemical Public Company Limited
F:GCB
-0.057x
Distil Plc
LSE:DIS
-0.129x

Annual Cash Flow Conversion Efficiency for Futura Medical (2001–2025)

The table below shows the annual cash flow conversion efficiency of Futura Medical from 2001 to 2025. View Futura Medical (FUM) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 GBX2.81 Million
≈ $341.31
GBX-5.58 Million
≈ $-678.54
-1.988x -4164.32%
2024-12-31 GBX8.96 Million
≈ $1.09K
GBX438.41K
≈ $53.34
0.049x -53.02%
2023-12-31 GBX5.48 Million
≈ $666.37
GBX570.25K
≈ $69.38
0.104x +108.51%
2022-12-31 GBX4.72 Million
≈ $574.23
GBX-5.78 Million
≈ $-702.69
-1.224x -207.24%
2021-12-31 GBX9.72 Million
≈ $1.18K
GBX-3.87 Million
≈ $-471.26
-0.398x +92.52%
2020-12-31 GBX853.54K
≈ $103.85
GBX-4.54 Million
≈ $-552.79
-5.323x +95.71%
2019-12-31 GBX53.65K
≈ $6.53
GBX-6.66 Million
≈ $-809.87
-124.063x -23226.94%
2018-12-31 GBX8.85 Million
≈ $1.08K
GBX-4.71 Million
≈ $-572.83
-0.532x -16.00%
2017-12-31 GBX9.11 Million
≈ $1.11K
GBX-4.17 Million
≈ $-507.95
-0.458x -74.94%
2016-12-31 GBX12.58 Million
≈ $1.53K
GBX-3.30 Million
≈ $-401.27
-0.262x +76.61%
2015-12-31 GBX4.79 Million
≈ $582.35
GBX-5.36 Million
≈ $-652.63
-1.121x -255.27%
2014-12-31 GBX9.72 Million
≈ $1.18K
GBX-3.07 Million
≈ $-373.13
-0.315x +84.53%
2013-12-31 GBX987.77K
≈ $120.18
GBX-2.01 Million
≈ $-245.04
-2.039x -201.85%
2012-12-31 GBX2.87 Million
≈ $349.59
GBX-1.94 Million
≈ $-236.14
-0.675x -1.47%
2011-12-31 GBX2.76 Million
≈ $335.57
GBX-1.84 Million
≈ $-223.39
-0.666x +42.71%
2010-12-31 GBX901.00K
≈ $109.63
GBX-1.05 Million
≈ $-127.39
-1.162x -63.37%
2009-12-31 GBX1.85 Million
≈ $225.46
GBX-1.32 Million
≈ $-160.36
-0.711x +68.03%
2008-12-31 GBX886.00K
≈ $107.80
GBX-1.97 Million
≈ $-239.81
-2.225x -170.33%
2007-12-31 GBX2.77 Million
≈ $337.39
GBX-2.28 Million
≈ $-277.65
-0.823x -75.43%
2006-12-31 GBX3.95 Million
≈ $480.36
GBX-1.85 Million
≈ $-225.33
-0.469x +56.29%
2005-12-31 GBX1.98 Million
≈ $240.91
GBX-2.12 Million
≈ $-258.55
-1.073x -177.22%
2004-12-31 GBX3.75 Million
≈ $456.02
GBX-1.45 Million
≈ $-176.54
-0.387x +31.27%
2003-12-31 GBX2.41 Million
≈ $293.11
GBX-1.36 Million
≈ $-165.11
-0.563x +19.43%
2003-01-31 GBX1.52 Million
≈ $184.82
GBX-1.06 Million
≈ $-129.21
-0.699x -8.85%
2002-01-31 GBX2.00 Million
≈ $243.22
GBX-1.28 Million
≈ $-156.23
-0.642x -159.76%
2001-01-31 GBX-294.00K
≈ $-35.77
GBX-316.00K
≈ $-38.45
1.075x --

About Futura Medical

LSE:FUM UK Biotechnology
Market Cap
$14.15K
GBX116.27 Million GBX
Market Cap Rank
#31794 Global
#1288 in UK
Share Price
GBX0.20
Change (1 day)
-4.76%
52-Week Range
GBX0.20 - GBX3.90
All Time High
GBX84.52
About

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Fut… Read more